Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification

Sponsor
Albert Einstein Healthcare Network (Other)
Overall Status
Recruiting
CT.gov ID
NCT04093973
Collaborator
Lantheus Medical Imaging (Industry)
100
1
91.7
1.1

Study Details

Study Description

Brief Summary

Many people develop calcium deposits in the heart as they get older. One of the common places for this to occur is the mitral annulus, the band of tissue that supports the mitral valve (one of four heart valves). The purpose of this study is to examine effects of these deposits (termed mitral annular calcification or "MAC") on a person's ability to perform exercise. The research team will use ultrasound of the heart (Doppler echocardiography) to study people with MAC while they exercise on a specially designed bicycle.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: bicycle stress echocardiography

Detailed Description

Mitral annular calcification (MAC) involves build-up of calcium in the mitral annulus, the fibro-muscular band which supports the mitral valve. The annulus aids in valve function, contracting in early systole (contraction phase) and bringing the valve leaflets together. In diastole (filling phase) it enlarges allowing blood to flow freely across the valve. Calcification stiffens the annulus and can extend onto the valve leaflets stiffening them. When severe, MAC impairs flow across the valve (mitral stenosis). This is characterized by a pressure gradient across the valve which can be detected by Doppler echocardiography (ultrasound).

Routine Doppler echocardiography is performed at rest when heart rates and flow across the mitral valve are low. Thus, even with severe MAC, there may only be a small pressure gradient present. However, with exercise these gradients can rise rapidly, leading to symptoms such as fatigue and shortness of breath.

MAC is associated with aging and is becoming more prevalent. Our hypothesis is that MAC is a common cause of shortness of breath with exertion. Further, the investigator believes this is under-appreciated because routine Doppler echocardiograms are done at rest. Therefore, the investigator will study adult subjects with moderate to severe MAC during bicycle exercise. Doppler echocardiography will be used to measure both the resting gradient across the mitral valve and changes with exercise. Symptoms will be measured by Borg Perceived Exertion scale.

If the research team is successful, the research team expects to demonstrate convincingly that this commonly encountered finding on Doppler echocardiography is an important cause of patient symptoms.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification
Actual Study Start Date :
Nov 7, 2014
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
MAC subjects

Outpatients with moderate to severe mitral annular calcification on echocardiogram who are able to perform supine bicycle exercise.

Diagnostic Test: bicycle stress echocardiography
Study subjects will perform supine bicycle exercise with echocardiography performed before, during, and after exercise. Definity (perflutren microbubble contrast agent) will be used as needed to enhance echo images.

Controls

Sex matched individuals who are within 5 years of age of the paired MAC subject and who have the same left ventricular wall thickness as measured by echocardiography.

Diagnostic Test: bicycle stress echocardiography
Study subjects will perform supine bicycle exercise with echocardiography performed before, during, and after exercise. Definity (perflutren microbubble contrast agent) will be used as needed to enhance echo images.

Outcome Measures

Primary Outcome Measures

  1. Change in mean mitral valve gradient from baseline to peak exercise in patients with Mitral Annular Calcification compared to controls. [Procedure day]

    Measuring how the pressure gradient across the mitral valve changes during exercise, and comparing these changes between subjects and controls.

Secondary Outcome Measures

  1. Change in pulmonary artery systolic pressure from baseline to peak exercise in patients with Mitral Annular Calcification compared to controls. [Procedure day]

    Measuring how the blood pressure in the lungs changes during exercise, and comparing these changes between subjects and controls.

  2. Borg Perceived Exertion Score at peak exercise in patients with Mitral Annular Calcification compared to controls. [Procedure day]

    Comparing perceived exertion during exercise between subjects and controls. The Borg Scale of Perceived Exertion takes into account an individual's fitness level: It matches how hard a subject feels he/she is working, using numbers from 6 to 20; thus, it is a "relative" scale. The scale starts with "no feeling of exertion," which rates a 6, and ends with "very, very hard," which rates a 20. Moderate activities register 11 to 14 on the Borg scale ("fairly light" to "somewhat hard"), while vigorous activities usually rate a 15 or higher ("hard" to "very, very hard").

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • At least moderate mitral annular calcification as judged by a previously published semi-quantitative echocardiographic score

  • Over 18 years of age

  • Able to use the semi-supine exercise bicycle

  • Should be able to give informed consent.

Exclusion Criteria:
  • Oxygen dependent lung or cardiac disease

  • Moderate or greater aortic valvular disease

  • Moderate or greater mitral regurgitation

  • Reduced left ventricular ejection fraction, <35%

  • Any diagnosed coronary disease

  • A resting mean gradient of ≥10 mmHg across the mitral valve.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Einstein Medical Center Philadelphia Pennsylvania United States 19141

Sponsors and Collaborators

  • Albert Einstein Healthcare Network
  • Lantheus Medical Imaging

Investigators

  • Principal Investigator: Gregg S Pressman, MD, Albert Einstein Healthcare Network

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gregg Pressman, Principal Investigator, Albert Einstein Healthcare Network
ClinicalTrials.gov Identifier:
NCT04093973
Other Study ID Numbers:
  • HN:4649
First Posted:
Sep 18, 2019
Last Update Posted:
Jul 23, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 23, 2021